Similarly, a trend for higher mean ALT was observed among the NAFLD patients compared with patients with no underlying liver disease (1814 vs. 1232 U/L; P-value by Student’s t-test: 0.292). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.